Ketamine Completed Phase 4 Trials for Psychoses, Substance-Induced Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00205712Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids